Skip to content

Shweta jeeraka in the management of Premenstrual syndrome.

A randomized placebo controlled clinical study to evaluate the efficacy of Shweta jeeraka (Cuminum cyminum Linn.) in the management of Premenstrual syndrome. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084141
Enrollment
40
Registered
2025-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

None listed

Sponsors

Dr Anusha Anant Hegde
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects between age group of 20 to 40 years, irrespective of their marital status. 2.Subjects presenting with mild to moderate symptoms of Premenstrual syndrome (PMS) with regular menstrual cycle. 3.Subjects who are willing to give written consent for the study.

Exclusion criteria

Exclusion criteria: 1.Subjects with irregular menstruation. 2.Subjects undergoing hormone therapy. 3.Subjects under alcohol use or any other substance abuse. 4.Subjects exhibiting symptoms continuous throughout the phase of menstrual cycle. 5. Subjects with underlying pathological conditions of breast and pelvis. 6. Subjects with Premenstrual Dysphoric Disorder (PMDD) and any pre-existing psychological disorder.

Design outcomes

Primary

MeasureTime frame
Significant improvement in the symptoms of Premenstrual syndrome. Timepoint: 1st assessment (BT)- 0th day 2nd assessment -5th day of the first cycle 3rd assessment - 5th day of the second cycle 4th assessment- 5th day of the third cycle 5th assessment (drug free)- 5th day of the fourth cycle

Secondary

MeasureTime frame
Improvement in quality of life Generation of in-depth analysed data on the different aspects of the disease. Generation of data on possible adverse drug reaction. Timepoint: 1st assessment (BT)- 0th day 2nd assessment -5th day of the first cycle 3rd assessment - 5th day of the second cycle 4th assessment- 5th day of the third cycle 5th assessment (drug free)- 5th day of the fourth cycle

Countries

India

Contacts

Public ContactDr Seema Pradeep

Sri Sri College of Ayurvedic Science and Research College and Hospital, Bangalore

ayurseema@gmail.com9448330936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026